Tianjin Sainuo Pharmaceutical

Tianjin Sainuo Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of cardiovascular and cerebrovascular medications. Founded in 1994 and headquartered in the Tianjin Economic-Technological Development Area (TEDA), the company operates as a key subsidiary of the Tianjin Pharmaceutical Group. Its product portfolio is centered on high-quality generic small molecules, including its flagship Buflomedil Hydrochloride treatments for peripheral vascular disorders. The company maintains modern GMP-certified manufacturing facilities and is recognized as a high-tech enterprise within the Tianjin region. Sainuo focuses on providing affordable and effective therapeutic solutions for chronic metabolic and vascular conditions in the domestic Chinese market.